PTC Therapeutics, Inc. today shared new data being presented from the Phase 3 APHENITY trial and subsequent open-label extension study at the 2025 American College of Medical Genetics and Genomics ...

A technician operates a multimodal medical imaging device in Beijing, capital of China, March 20, 2025. (Xinhua/Jin Liwang)BEIJING, March 22 (Xinhua) ...

Referred to as a "life observatory," the facility enables trans-scale and panoramic observation to reveal life's mysteries, said Cheng Heping, director and chief scientist of the National Biomedical ...

Feb. 19, 2025 — New research focuses on diagnostic delays experienced by people with epilepsy, a neurological disorder characterized by unpredictable seizures that affects over 3 million people ...

Referred to as a "life observatory," the facility enables trans-scale and panoramic observation to reveal life's mysteries, said Cheng Heping, director and chief scientist of the National Biomedical ...

Join us for Purple Day ® on March 26 to harness the Power In Purple, the Epilepsy Foundation’s 2025 theme emphasizing the strength and resilience of the epilepsy community. Together, we can turn ...